These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. TNF-alpha induces the generation of Langerin/(CD207)+ immature Langerhans-type dendritic cells from both CD14-CD1a and CD14+CD1a- precursors derived from CD34+ cord blood cells. Arrighi JF; Soulas C; Hauser C; Saeland S; Chapuis B; Zubler RH; Kindler V Eur J Immunol; 2003 Jul; 33(7):2053-63. PubMed ID: 12884872 [TBL] [Abstract][Full Text] [Related]
4. Anatomic localization of immature and mature dendritic cells in an ectopic lymphoid organ: correlation with selective chemokine expression in rheumatoid synovium. Page G; Lebecque S; Miossec P J Immunol; 2002 May; 168(10):5333-41. PubMed ID: 11994492 [TBL] [Abstract][Full Text] [Related]
5. CD34+ cell-derived CD14+ precursor cells develop into Langerhans cells in a TGF-beta 1-dependent manner. Jaksits S; Kriehuber E; Charbonnier AS; Rappersberger K; Stingl G; Maurer D J Immunol; 1999 Nov; 163(9):4869-77. PubMed ID: 10528188 [TBL] [Abstract][Full Text] [Related]
6. Differential effects of autologous serum on CD34(+) or monocyte-derived dendritic cells. Loudovaris M; Hansen M; Suen Y; Lee SM; Casing P; Bender JG J Hematother Stem Cell Res; 2001 Aug; 10(4):569-78. PubMed ID: 11522239 [TBL] [Abstract][Full Text] [Related]
7. Corticosteroids prevent generation of CD34+-derived dermal dendritic cells but do not inhibit Langerhans cell development. Woltman AM; Massacrier C; de Fijter JW; Caux C; van Kooten C J Immunol; 2002 Jun; 168(12):6181-8. PubMed ID: 12055231 [TBL] [Abstract][Full Text] [Related]
8. Dendritic cell infiltration and prognosis of early stage breast cancer. Treilleux I; Blay JY; Bendriss-Vermare N; Ray-Coquard I; Bachelot T; Guastalla JP; Bremond A; Goddard S; Pin JJ; Barthelemy-Dubois C; Lebecque S Clin Cancer Res; 2004 Nov; 10(22):7466-74. PubMed ID: 15569976 [TBL] [Abstract][Full Text] [Related]
9. Dendritic cells differently respond to haptens and irritants by their production of cytokines and expression of co-stimulatory molecules. Aiba S; Terunuma A; Manome H; Tagami H Eur J Immunol; 1997 Nov; 27(11):3031-8. PubMed ID: 9394834 [TBL] [Abstract][Full Text] [Related]
10. Activin A induces Langerhans cell differentiation in vitro and in human skin explants. Musso T; Scutera S; Vermi W; Daniele R; Fornaro M; Castagnoli C; Alotto D; Ravanini M; Cambieri I; Salogni L; Elia AR; Giovarelli M; Facchetti F; Girolomoni G; Sozzani S PLoS One; 2008 Sep; 3(9):e3271. PubMed ID: 18813341 [TBL] [Abstract][Full Text] [Related]
11. Production of large numbers of Langerhans' cells with intraepithelial migration ability in vitro. Hubert P; Bousarghin L; Greimers R; Franzen-Detrooz E; Boniver J; Delvenne P Exp Dermatol; 2005 Jun; 14(6):469-77. PubMed ID: 15885083 [TBL] [Abstract][Full Text] [Related]
12. Langerin (CD207) staining in normal pediatric tissues, reactive lymph nodes, and childhood histiocytic disorders. Chikwava K; Jaffe R Pediatr Dev Pathol; 2004; 7(6):607-14. PubMed ID: 15630529 [TBL] [Abstract][Full Text] [Related]
13. Special susceptibility to apoptosis of CD1a+ dendritic cell precursors differentiating from cord blood CD34+ progenitors. Canque B; Camus S; Yagello M; Gluckman JC Stem Cells; 1998; 16(3):218-28. PubMed ID: 9617897 [TBL] [Abstract][Full Text] [Related]
14. Langerhans cells utilize CD1a and langerin to efficiently present nonpeptide antigens to T cells. Hunger RE; Sieling PA; Ochoa MT; Sugaya M; Burdick AE; Rea TH; Brennan PJ; Belisle JT; Blauvelt A; Porcelli SA; Modlin RL J Clin Invest; 2004 Mar; 113(5):701-8. PubMed ID: 14991068 [TBL] [Abstract][Full Text] [Related]
15. Preferential Langerhans cell differentiation from CD34(+) precursors upon introduction of ABCG2 (BCRP). van de Ven R; Lindenberg JJ; Reurs AW; Scheper RJ; Scheffer GL; de Gruijl TD Immunol Cell Biol; 2012 Feb; 90(2):206-15. PubMed ID: 21445088 [TBL] [Abstract][Full Text] [Related]
16. Langerin+ dermal dendritic cells are critical for CD8+ T cell activation and IgH γ-1 class switching in response to gene gun vaccines. Stoecklinger A; Eticha TD; Mesdaghi M; Kissenpfennig A; Malissen B; Thalhamer J; Hammerl P J Immunol; 2011 Feb; 186(3):1377-83. PubMed ID: 21187444 [TBL] [Abstract][Full Text] [Related]